|Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation|
K Coyle, D Coyle, A Lester‐George, R West, B Nemeth, M Hiligsmann, ...
|Guidance toward the implementation of multicriteria decision analysis framework in developing countries|
A Inotai, HT Nguyen, B Hidayat, T Nurgozhin, PHT Kiet, JD Campbell, ...
Expert review of pharmacoeconomics & outcomes research 18 (6), 585-592, 2018
|Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD|
M Trapero‐Bertran, C Muñoz, K Coyle, D Coyle, A Lester‐George, R Leidl, ...
Addiction 113, 65-75, 2018
|A systematic review of the indirect costs of schizophrenia in Europe|
A Fasseeh, B Németh, A Molnár, FU Fricke, M Horváth, K Kóczián, ...
European journal of public health 28 (6), 1043-1049, 2018
|Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone|
B Németh, A Molnár, R Akehurst, M Horváth, K Kóczián, G Németh, ...
Journal of comparative effectiveness research 6 (8), 639-648, 2017
|Overview on the current implementation of health technology assessment in the healthcare system in Hungary|
B Németh, M Csanádi, Z Kaló
International journal of technology assessment in health care 33 (3), 333-338, 2017
|Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals–an application on improving tender decision making in Indonesia|
A Inotai, D Brixner, N Maniadakis, I Dwiprahasto, E Kristin, A Prabowo, ...
BMC health services research 18 (1), 1003, 2018
|Drug Policy in Central Eastern Europe—Hungary|
A Inotai, M Csanádi, A Harsányi, B Németh
Value in health regional issues 13, 16-22, 2017
|A systematic review of health economic models and utility estimation methods in schizophrenia|
B Németh, A Fasseeh, A Molnár, I Bitter, M Horváth, K Kóczián, Á Götze, ...
Expert review of pharmacoeconomics & outcomes research 18 (3), 267-275, 2018
|Evidence requirements for reimbursement of pharmaceuticals across Europe|
O Oyebode, Z Garrett, E George, A Cangini, LAA Muscolo, S Warren, ...
International journal of technology assessment in health care 31 (1-2), 59-67, 2015
|Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD|
MB Huber, M Präger, K Coyle, D Coyle, A Lester‐George, ...
Addiction 113, 52-64, 2018
|Mcda Application In Central And Eastern Europe: Selection Of The Most Important Criteria Based On Examples|
B Nemeth, O Piniazhko
Value in Health 19 (7), A471, 2016
|Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries|
B Németh, A Molnár, S Bozóki, K Wijaya, A Inotai, JD Campbell, Z Kaló
Journal of comparative effectiveness research 8 (4), 195-204, 2019
|PRACTICAL ISSUES OF DETERMINING WEIGHTS FOR CRITERIA TO BE USED IN AN MCDA FRAMEWORK-BASED ON A CASE-STUDY|
O Piniazhko, B Nemeth
VALUE IN HEALTH 20 (5), A51-A52, 2017
|The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment|
B Nemeth, Á Vincziczki
Value in Health 16 (7), A592-A593, 2013
|Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations-A meeting report from ISPOR regional conference in Warsaw, 2019|
A Inotai, B Németh
Expert review of pharmacoeconomics & outcomes research 19 (4), 379-381, 2019
|Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia|
B Németh, R Bendes, B Nagy, Á Götze, K Kóczián, M Horváth, I Deák, ...
Health Policy and Technology 8 (1), 84-91, 2019
|Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives|
M Csanádi, A Inotai, O Oleshchuk, O Lebega, B Alexandra, O Piniazhko, ...
International journal of technology assessment in health care 35 (5), 393-400, 2019
|Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD|
B Németh, J Józwiak‐Hagymásy, G Kovács, A Kovács, T Demjén, ...
Addiction 113, 76-86, 2018
|A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study|
B Németh, P Kulchaitanaroaj, A Lester‐George, M Huic, K Coyle, D Coyle, ...
Addiction 113, 42-51, 2018